CompaniesBiotech & healthTrogenix Ltd
Download
Company intelligence · Prepared from public filings

Trogenix Ltd

ACTIVENo. 14930146Incorporated 12 Jun 2023Londongene therapies for solid tumours
Register data as of 27 Aug 2026
8 filings read · view all sources ↓
Watch this company
Raised, filed rounds
£31.6m
Priced rounds
5
Peak step-up
1.7x
Peak implied valuation
£49.9m
Last allotment
Oct 2025
Exhibit 1

Implied valuation at each priced allotment, 2024 to 2025

Implied post-money, GBP · price per share beneath each point · from SH01 filings
£14.0m£27.9m£41.9m£55.9m202420259 Feb 2024: £9.5m implied post-money at £100 per share16 Aug 2024: £17.9m implied post-money at £100 per share23 Dec 2024: £18.5m implied post-money at £100 per share7 Oct 2025: £35.8m implied post-money at £170 per share17 Oct 2025: £49.9m implied post-money at £170 per share£9.5m£100/sh£17.9m£100/sh£18.5m£100/sh£35.8m£170/sh£49.9m£170/sh
Source: Companies House, forms SH01 filed by Trogenix Ltd; Tero analysis. Each point is one filed allotment; click any point to open the underlying filing.
Exhibit 2

Funding rounds, as filed

AllottedShare classPrice / shareRaisedImplied post-moneyStep vs priorSource
17 Oct 2025Series A1 Shares£170£14.1m£49.9m· 1.0xSH01 ↗
7 Oct 2025A Ordinary£170£4.2m£35.8m▲ 1.7xSH01 ↗
23 Dec 2024Ordinary and Seed£100£592k£18.5m· 1.0xSH01 ↗
16 Aug 2024Ordinary and Seed£100£8.4m£17.9m· 1.0xSH01 ↗
9 Feb 2024Ordinary, Seed£100£4.4m£9.5mfirstSH01 ↗
Total, 5 priced rounds£31.6m
Source: Companies House filing history, company 14930146. Every row links to the filed document it was read from. Prices and share counts as filed; implied post-money is price per share times shares in issue after the allotment.
Methodology
Notes. Raised is the sum of shares allotted times price per share across priced allotments filed on form SH01. Peak step-up is the highest price per share divided by the first priced round. Implied post-money is price per share times shares in issue after the allotment: an approximation that ignores class rights and unexercised options. Allotments classified as option-scheme or nominal issues are excluded from the trajectory.
Primary documents
Every figure on this page is read from a document filed at Companies House and links to it. The full record is public: filing history of Trogenix Ltd at Companies House ↗. Tero retains an archived copy of each parsed filing. Information, not investment advice.